Form 4: Genelux CFO Lourie S. Zak Acquires Shares and Stock Options

Genelux Corp's Chief Financial Officer, Lourie S. Zak, acquired 41,650 shares of common stock and 56,525 stock options on December 18, 2024.

Summary

• Lourie S. Zak, the Chief Financial Officer of Genelux Corp, reported a transaction on December 18, 2024.
• Mr. Zak acquired 41,650 shares of common stock through restricted stock units (RSUs) at a price of $0.
• He also acquired 56,525 stock options with an exercise price of $2.29.
• The stock options vest over time, with 25% vesting on August 1, 2025, and the remainder vesting in 36 equal monthly installments.
• The RSUs also vest over time, with 25% vesting on August 1, 2025, and the remainder vesting in 12 equal quarterly installments.
• Following these transactions, Mr. Zak directly owns 82,452 shares of common stock and 56,525 stock options.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of insider transactions. It is neither particularly positive nor negative, but the acquisition of shares by the CFO could be seen as a slightly positive sign.

Positives

• The acquisition of shares and options by the CFO could be seen as a positive sign of confidence in the company's future.

Industry Context

This is a standard SEC Form 4 filing, which is common for publicly traded companies when insiders make transactions in their company's stock. It is a routine disclosure and does not indicate any specific industry trend.

Comparison to Industry Standards

• The vesting schedule of the stock options and RSUs is typical for equity compensation plans in the biotechnology industry.
• The use of RSUs and stock options is a common practice for incentivizing executives in publicly traded companies, particularly in growth-oriented sectors like biotech.
• The exercise price of $2.29 for the stock options is a standard practice, often set at or above the market price at the time of grant.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment, as it indicates the CFO's confidence in the company.

Key Dates

Keywords

Genelux, Lourie S. Zak, CFO, stock options, restricted stock units, RSUs, insider trading, equity incentive plan, vesting